Thrivent Financial for Lutherans’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.5M | Sell |
|
|||||
|
2025
Q1 | $117M | Sell |
|
|||||
|
2024
Q4 | $110M | Sell |
|
|||||
|
2024
Q3 | $183M | Buy |
|
|||||
|
2024
Q2 | $148M | Buy |
|
|||||
|
2024
Q1 | $65.7M | Sell |
|
|||||
|
2023
Q4 | $117M | Sell |
|
|||||
|
2023
Q3 | $114M | Sell |
|
|||||
|
2023
Q2 | $124M | Buy |
|
|||||
|
2023
Q1 | $133M | Sell |
|
|||||
|
2022
Q4 | $162M | Buy |
|
|||||
|
2022
Q3 | $114M | Buy |
|
|||||
|
2022
Q2 | $56M | Sell |
|
|||||
|
2022
Q1 | $63.5M | Buy |
|
|||||
|
2021
Q4 | $57.1M | Buy |
|
|||||
|
2021
Q3 | $49M | Buy |
|
|||||
|
2021
Q2 | $38.5M | Buy |
|
|||||
|
2021
Q1 | $20.7M | Sell |
|
|||||
|
2020
Q4 | $21.4M | Sell |
|
|||||
|
2020
Q3 | $38.3M | Buy |
|
|||||
|
2020
Q2 | $44.1M | Sell |
|
|||||
|
2020
Q1 | $43.7M | Sell |
|
|||||
|
2019
Q4 | $114M | Sell |
|
|||||
|
2019
Q3 | $116M | Buy |
|
|||||
|
2019
Q2 | $118M | Buy |
|
|||||
|
2019
Q1 | $85.4M | Buy |
|
|||||
|
2018
Q4 | $62.3M | Buy |
|
|||||
|
2018
Q3 | $69.3M | Buy |
|
|||||
|
2018
Q2 | $3.87M | Buy |
|
|||||
|
2018
Q1 | $4.11M | Buy |
|
|||||
|
2017
Q4 | $3.82M | Buy |
|
|||||
|
2017
Q3 | $4.23M | Buy |
|
|||||
|
2017
Q2 | $3.51M | Sell |
|
|||||
|
2017
Q1 | $117M | Sell |
|
|||||
|
2016
Q4 | $162M | Buy |
|
|||||
|
2016
Q3 | $175M | Buy |
|
|||||
|
2016
Q2 | $145M | Sell |
|
|||||
|
2016
Q1 | $164M | Buy |
|
|||||
|
2015
Q4 | $156M | Buy |
|
|||||
|
2015
Q3 | $136M | Sell |
|
|||||
|
2015
Q2 | $197M | Sell |
|
|||||
|
2015
Q1 | $175M | Sell |
|
|||||
|
2014
Q4 | $196M | Sell |
|
|||||
|
2014
Q3 | $263M | Sell |
|
|||||
|
2014
Q2 | $251M | Sell |
|
|||||
|
2014
Q1 | $230M | Buy |
|
|||||
|
2013
Q4 | $237M | Buy |
|
|||||
|
2013
Q3 | $197M | Sell |
|
|||||
|
2013
Q2 | $168K | Buy |
|